Weichia Chen, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 3 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
18 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chen’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A97424 · Current
Licensed to practise in California · since 2006 · expires 2028-09-30 · University of California, San Diego School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$64,677
Medicare paid this office $64,677 for 298 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 70 | $37,802 | $186 |
| Return visit (30+ min) | 115 | $15,484 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 38 | $3,060 | $71 |
| Short return visit (20+ min) | 37 | $2,003 | $51 |
| New patient visit (45+ min) | 18 | $1,967 | $109 |
See all 9 services
| Critical care, first 30-74 minutes | 70 | $37,802 | $186 |
| Return visit (30+ min) | 115 | $15,484 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 38 | $3,060 | $71 |
| Short return visit (20+ min) | 37 | $2,003 | $51 |
| New patient visit (45+ min) | 18 | $1,967 | $109 |
| Test to determine lung volumes using sensors | 35 | $330 | $9 |
| Test to examine how well the lungs exchange gases | 38 | $252 | $7 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 24 | $173 | $7 |
| Test to measure expiratory airflow and volume | 20 | $138 | $7 |
Who their Medicare patients are
298 Original Medicare patients in 2024. Average age 72 · Under 65 16% · 85 and older 14% · Women 50% · Also on Medicaid 83% · Health risk score 2.94. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Diabetes 51% · COPD 49% · Heart failure 40% · Chronic kidney disease 34% · Coronary heart disease 33% · Atrial fibrillation 26% · Depression 26% · Stroke 18% · Cancer 16% · Dementia 16%.
The office billed $687,398, Medicare allowed $84,714 and paid $64,677; for 676 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 298 | 676 | 72 | 2.94 | $687,398 | $64,677 |
| 2023 | 235 | 537 | 71 | 2.41 | $547,155 | $55,249 |
| 2022 | 224 | 484 | 70 | 1.77 | $407,012 | $48,292 |
| 2021 | 220 | 515 | 72 | 2.41 | $488,478 | $62,314 |
| 2020 | 251 | 598 | 70 | 2.52 | $564,858 | $69,636 |
| 2019 | 322 | 699 | 70 | 2.61 | $613,107 | $64,456 |
| 2018 | 295 | 618 | 70 | 2.30 | $532,297 | $58,866 |
| 2017 | 244 | 571 | 71 | 2.25 | $473,977 | $54,237 |
| 2016 | 171 | 389 | 70 | 2.47 | $326,141 | $43,017 |
| 2015 | 202 | 455 | 67 | 2.36 | $295,989 | $42,333 |
| 2014 | 278 | 589 | 68 | 2.09 | $333,809 | $51,741 |
| 2013 | 244 | 444 | 68 | 2.10 | $205,907 | $37,531 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Critical care, first 30-74 minutes | 63 | $31,708 | $195 |
| Return visit (30+ min) | 90 | $12,809 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $3,265 | $74 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,399 | $150 |
| Short return visit (20+ min) | 31 | $1,431 | $45 |
| Test to determine lung volumes using sensors | 27 | $281 | $10 |
| Test to examine how well the lungs exchange gases | 27 | $210 | $8 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 15 | $131 | $9 |
| Test to measure expiratory airflow and volume | 17 | $120 | $7 |
2022: 11 services
| Critical care, first 30-74 minutes | 47 | $23,096 | $220 |
| Return visit (30+ min) | 72 | $7,522 | $86 |
| Telephone medical discussion with physician, 21-30 minutes | 34 | $5,029 | $73 |
| Short return visit (20+ min) | 47 | $3,277 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $3,028 | $216 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $2,540 | $79 |
| Telephone medical discussion with physician, 5-10 minutes | 15 | $382 | $22 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $373 | $34 |
| Test to determine lung volumes using sensors | 14 | $110 | $8 |
| Test to examine how well the lungs exchange gases | 17 | $98 | $6 |
| Test to measure expiratory airflow and volume | 12 | $76 | $6 |
2021: 7 services
| Critical care, first 30-74 minutes | 57 | $35,553 | $222 |
| Telephone medical discussion with physician, 21-30 minutes | 43 | $8,763 | $90 |
| Return visit (30+ min) | 63 | $6,721 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $3,849 | $77 |
| Short return visit (20+ min) | 24 | $1,550 | $57 |
| Telephone medical discussion with physician, 5-10 minutes | 21 | $771 | $34 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $755 | $63 |
2020: 8 services
| Critical care, first 30-74 minutes | 58 | $46,680 | $228 |
| Telephone medical discussion with physician, 21-30 minutes | 51 | $4,957 | $73 |
| Return visit (30+ min) | 47 | $3,758 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $3,602 | $80 |
| Telephone medical discussion with physician, 11-20 minutes | 71 | $3,580 | $42 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $3,022 | $216 |
| Short return visit (20+ min) | 34 | $835 | $24 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $384 | $23 |
2019: 9 services
| Critical care, first 30-74 minutes | 83 | $35,433 | $193 |
| Return visit (30+ min) | 122 | $9,914 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 55 | $6,149 | $66 |
| Short return visit (20+ min) | 81 | $4,112 | $40 |
| New patient visit (45+ min) | 25 | $2,128 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,084 | $174 |
| Test to determine lung volumes using sensors | 15 | $170 | $11 |
| Test to measure expiratory airflow and volume | 20 | $140 | $7 |
| Test to examine how well the lungs exchange gases | 14 | $117 | $8 |
2018: 6 services
| Critical care, first 30-74 minutes | 61 | $28,720 | $193 |
| Return visit (30+ min) | 112 | $9,832 | $63 |
| Short return visit (20+ min) | 84 | $5,044 | $43 |
| New patient visit (45+ min) | 44 | $4,097 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $3,897 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,275 | $182 |
2017: 9 services
| Critical care, first 30-74 minutes | 57 | $32,997 | $191 |
| Return visit (30+ min) | 94 | $8,700 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 36 | $4,380 | $63 |
| Short return visit (20+ min) | 43 | $2,124 | $41 |
| New patient visit (45+ min) | 12 | $1,085 | $90 |
| Test to determine lung volumes using sensors | 23 | $193 | $8 |
| Test to measure expiratory airflow and volume | 22 | $141 | $6 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 14 | $138 | $10 |
| Test to examine how well the lungs exchange gases | 19 | $121 | $6 |
2016: 5 services
| Critical care, first 30-74 minutes | 49 | $29,773 | $191 |
| Return visit (30+ min) | 61 | $5,042 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,508 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,101 | $175 |
| Short return visit (20+ min) | 37 | $1,504 | $39 |
2015: 8 services
| Critical care, first 30-74 minutes | 51 | $25,951 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 40 | $4,690 | $62 |
| Return visit (30+ min) | 55 | $4,238 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,842 | $175 |
| Short return visit (20+ min) | 37 | $1,430 | $37 |
| Test to determine lung volumes using sensors | 23 | $247 | $10 |
| Test to measure expiratory airflow and volume | 28 | $198 | $7 |
| Test to examine how well the lungs exchange gases | 21 | $167 | $8 |
2014: 9 services
| Critical care, first 30-74 minutes | 71 | $33,343 | $194 |
| Return visit (30+ min) | 68 | $4,687 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 34 | $3,972 | $63 |
| Short return visit (20+ min) | 74 | $3,466 | $41 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,979 | $180 |
| Test to determine lung volumes using sensors | 38 | $420 | $11 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 27 | $329 | $12 |
| Test to examine how well the lungs exchange gases | 35 | $286 | $8 |
| Test to measure expiratory airflow and volume | 28 | $212 | $8 |
2013: 8 services
| Critical care, first 30-74 minutes | 50 | $20,305 | $190 |
| Return visit (30+ min) | 86 | $7,265 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $2,930 | $62 |
| Short return visit (20+ min) | 56 | $2,453 | $39 |
| Long return visit (40+ min) | 25 | $1,812 | $72 |
| Test to determine lung volumes using sensors | 17 | $196 | $12 |
| Test to measure expiratory airflow and volume | 20 | $145 | $7 |
| Test to examine how well the lungs exchange gases | 16 | $135 | $8 |
Medicaid work
$12,932 in 2024
Medicaid paid $12,932 for 2,426 billed services this clinician did in 2024, up to 71 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 174 | $8,630 |
| Return visit (30+ min) | 465 | $2,550 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 99 | $824 |
| Smoking and tobacco use cessation counseling visit; intensive, greater than 10 minutes | 94 | $627 |
| Short return visit (20+ min) | 34 | $107 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 16 | $72 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 52 | $39 |
| New patient visit (45+ min) | 12 | $31 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 29 | $28 |
| Diffusing capacity | 52 | $25 |
| Pain severity quantified; pain present (COA) (ONC) | 12 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 28 | $0 |
| 2024 | 2,426 | 19 | 71 | $12,932 |
| 2023 | 1,493 | 14 | 60 | $14,302 |
| 2022 | 1,212 | 11 | 71 | $10,526 |
| 2021 | 485 | 7 | 35 | $15,331 |
| 2020 | 345 | 4 | 40 | $13,799 |
| 2019 | 1,168 | 9 | 43 | $17,465 |
| 2018 | 1,138 | 8 | 52 | $14,723 |
See the largest Medicaid services in earlier years
2023
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 301 | $8,974 |
| Return visit (30+ min) | 458 | $2,697 |
| Short return visit (20+ min) | 302 | $1,141 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 82 | $734 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 38 | $321 |
| New patient visit (45+ min) | 15 | $214 |
| EVALUATION OF WHEEZING | 17 | $75 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 53 | $60 |
| Diffusing capacity | 55 | $49 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 20 | $34 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 70 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 24 | $0 |
2022
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 105 | $4,317 |
| Short return visit (20+ min) | 462 | $2,682 |
| Return visit (30+ min) | 178 | $1,016 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 173 | $732 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 37 | $627 |
| New patient visit (45+ min) | 12 | $411 |
| Short return visit | 58 | $254 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 45 | $152 |
| Long return visit (40+ min) | 52 | $127 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 42 | $104 |
| Diffusing capacity | 48 | $104 |
2021
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 204 | $13,458 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 14 | $527 |
| Return visit (30+ min) | 74 | $526 |
| Short return visit (20+ min) | 116 | $477 |
| Long return visit (40+ min) | 24 | $209 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 26 | $76 |
| Diffusing capacity | 27 | $58 |
2020
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 172 | $11,797 |
| Return visit (30+ min) | 99 | $1,441 |
| Short return visit (20+ min) | 60 | $561 |
| Short return visit | 14 | $0 |
2019
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 248 | $11,622 |
| Return visit (30+ min) | 339 | $2,150 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 65 | $1,603 |
| Short return visit (20+ min) | 296 | $936 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 49 | $824 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 76 | $117 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 35 | $83 |
| EVALUATION OF WHEEZING | 26 | $74 |
| Diffusing capacity | 34 | $55 |
2018
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 171 | $7,255 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 214 | $3,600 |
| Return visit (30+ min) | 313 | $1,756 |
| Short return visit (20+ min) | 321 | $1,169 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 51 | $758 |
| Plethysmography for determination of lung volumes and, when performed, airway resistance | 25 | $94 |
| Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation | 30 | $52 |
| Diffusing capacity | 13 | $41 |
Drugs they prescribed that Part D paid
$638,350
Pharmacies billed $638,350 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 814) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
312 generic and 502 brand-name prescriptions · $638,350 in drug cost · 66 antibiotic prescriptions to 23 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ofev | 29 | $348,892 | $12,031 |
| Dupixent | 24 | $82,387 | $3,433 |
| Nucala | 11 | $38,747 | $3,522 |
| Breo Ellipta | 71 | $24,212 | $341 |
| Spiriva Handihaler | 39 | $21,604 | $554 |
See all 26 drugs
| Ofev | 29 | $348,892 | $12,031 |
| Dupixent | 24 | $82,387 | $3,433 |
| Nucala | 11 | $38,747 | $3,522 |
| Breo Ellipta | 71 | $24,212 | $341 |
| Spiriva Handihaler | 39 | $21,604 | $554 |
| Incruse Ellipta | 46 | $17,517 | $381 |
| Spiriva Respimat | 21 | $10,332 | $492 |
| Pirfenidone | 11 | $9,843 | $895 |
| Combivent Respimat | 22 | $9,552 | $434 |
| Trelegy Ellipta | 11 | $6,310 | $574 |
| Fluticasone Propionate Hfa | 21 | $5,659 | $269 |
| Stiolto Respimat | 12 | $5,591 | $466 |
| Arnuity Ellipta | 11 | $3,534 | $321 |
| Albuterol Sulfate Hfa | 87 | $3,239 | $37 |
| Dulera | 11 | $3,226 | $293 |
| Fluticasone-Salmeterol | 13 | $2,519 | $194 |
| Ventolin Hfa | 41 | $2,238 | $55 |
| Wixela Inhub | 13 | $1,953 | $150 |
| Azithromycin | 48 | $422 | $9 |
| Montelukast | 54 | $225 | $4 |
| Gabapentin | 15 | $159 | $11 |
| Omeprazole | 23 | $90 | $4 |
| Fluticasone Propionate | 11 | $89 | $8 |
| Prednisone | 20 | $89 | $4 |
| Pantoprazole | 19 | $58 | $3 |
| Furosemide | 22 | $45 | $2 |
Year by year
| 2024 | 814 | 142 | 0% (0) | 62% | $638,350 |
| 2023 | 697 | 134 | None | 64% | $830,277 |
| 2022 | 557 | 132 | None | 57% | $267,844 |
| 2021 | 569 | 122 | None | 63% | $336,594 |
| 2020 | 626 | 128 | None | 64% | $280,337 |
| 2019 | 638 | 138 | None | 70% | $269,481 |
| 2018 | 618 | 131 | None | 63% | $131,104 |
| 2017 | 671 | 129 | 0% (0) | 72% | $186,356 |
| 2016 | 624 | 131 | None | 70% | $125,291 |
| 2015 | 459 | 120 | None | 66% | $173,209 |
| 2014 | 456 | 116 | None | 68% | $132,450 |
| 2013 | 294 | 92 | None | 66% | $41,306 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Ofev | 46 | $589,942 | $12,825 |
| Dupixent | 16 | $59,767 | $3,735 |
| Nucala | 13 | $44,731 | $3,441 |
| Spiriva Handihaler | 34 | $22,817 | $671 |
| Symbicort | 39 | $16,457 | $422 |
| Spiriva Respimat | 32 | $15,874 | $496 |
| Advair Diskus | 23 | $12,048 | $524 |
| Flovent Hfa | 31 | $9,986 | $322 |
| Incruse Ellipta | 19 | $8,823 | $464 |
| Ventolin Hfa | 59 | $4,289 | $73 |
| Breo Ellipta | 11 | $4,101 | $373 |
| Albuterol Sulfate Hfa | 71 | $3,896 | $55 |
| Sildenafil Citrate | 15 | $2,819 | $188 |
| Azithromycin | 44 | $946 | $22 |
| Montelukast | 44 | $510 | $12 |
| Fluticasone Propionate | 15 | $448 | $30 |
| Pantoprazole | 11 | $354 | $32 |
| Prednisone | 34 | $288 | $8 |
| Omeprazole | 12 | $173 | $14 |
2022: 17 drugs
| Dupixent | 12 | $27,833 | $2,319 |
| Advair Diskus | 39 | $16,026 | $411 |
| Spiriva Handihaler | 19 | $14,941 | $786 |
| Symbicort | 26 | $11,055 | $425 |
| Spiriva Respimat | 19 | $8,758 | $461 |
| Anoro Ellipta | 18 | $8,578 | $477 |
| Flovent Hfa | 23 | $7,239 | $315 |
| Eliquis | 12 | $6,170 | $514 |
| Breo Ellipta | 11 | $4,134 | $376 |
| Albuterol Sulfate Hfa | 58 | $2,864 | $49 |
| Ventolin Hfa | 42 | $2,232 | $53 |
| Azithromycin | 40 | $1,207 | $30 |
| Sildenafil Citrate | 22 | $906 | $41 |
| Montelukast | 45 | $373 | $8 |
| Omeprazole | 24 | $264 | $11 |
| Fluticasone Propionate | 14 | $228 | $16 |
| Prednisone | 20 | $126 | $6 |
2021: 19 drugs
| Ofev | 13 | $137,802 | $10,600 |
| Nucala | 20 | $69,021 | $3,451 |
| Dupixent | 13 | $28,650 | $2,204 |
| Advair Diskus | 51 | $20,024 | $393 |
| Spiriva | 23 | $17,547 | $763 |
| Symbicort | 20 | $10,278 | $514 |
| Flovent Hfa | 25 | $7,499 | $300 |
| Breo Ellipta | 19 | $6,875 | $362 |
| Spiriva Respimat | 13 | $6,083 | $468 |
| Incruse Ellipta | 12 | $4,403 | $367 |
| Albuterol Sulfate Hfa | 51 | $2,187 | $43 |
| Ventolin Hfa | 41 | $2,176 | $53 |
| Sildenafil Citrate | 13 | $1,313 | $101 |
| Azithromycin | 28 | $851 | $30 |
| Montelukast | 36 | $334 | $9 |
| Omeprazole | 29 | $311 | $11 |
| Fluticasone Propionate | 13 | $253 | $19 |
| Prednisone | 24 | $207 | $9 |
| Furosemide | 12 | $34 | $3 |
2020: 20 drugs
| Dupixent | 15 | $33,221 | $2,215 |
| Spiriva | 35 | $20,972 | $599 |
| Advair Diskus | 48 | $20,562 | $428 |
| Symbicort | 32 | $14,595 | $456 |
| Incruse Ellipta | 24 | $8,537 | $356 |
| Dulera | 22 | $6,578 | $299 |
| Flovent Hfa | 22 | $5,925 | $269 |
| Atrovent Hfa | 13 | $5,566 | $428 |
| Eliquis | 12 | $5,492 | $458 |
| Anoro Ellipta | 11 | $4,906 | $446 |
| Qvar Redihaler | 18 | $4,637 | $258 |
| Breo Ellipta | 13 | $4,626 | $356 |
| Ventolin Hfa | 43 | $2,558 | $59 |
| Albuterol Sulfate Hfa | 32 | $1,671 | $52 |
| Fluticasone Propionate | 28 | $435 | $16 |
| Mycophenolate Mofetil | 11 | $416 | $38 |
| Azithromycin | 23 | $361 | $16 |
| Prednisone | 44 | $343 | $8 |
| Montelukast | 43 | $306 | $7 |
| Omeprazole | 18 | $123 | $7 |
2019: 19 drugs
| Symbicort | 49 | $20,038 | $409 |
| Advair Diskus | 39 | $17,284 | $443 |
| Spiriva | 24 | $16,508 | $688 |
| Incruse Ellipta | 39 | $13,552 | $347 |
| Breo Ellipta | 30 | $10,284 | $343 |
| Anoro Ellipta | 22 | $9,116 | $414 |
| Eliquis | 11 | $8,410 | $765 |
| Qvar Redihaler | 29 | $6,732 | $232 |
| Flovent Hfa | 15 | $5,286 | $352 |
| Atrovent Hfa | 12 | $4,681 | $390 |
| Ventolin Hfa | 57 | $3,735 | $66 |
| Pulmicort Flexhaler | 11 | $2,715 | $247 |
| Albuterol Sulfate Hfa | 22 | $1,280 | $58 |
| Proair Hfa | 19 | $875 | $46 |
| Fluticasone Propionate | 32 | $320 | $10 |
| Azithromycin | 14 | $281 | $20 |
| Montelukast | 33 | $260 | $8 |
| Prednisone | 18 | $102 | $6 |
| Omeprazole | 13 | $71 | $5 |
2018: 15 drugs
| Advair Diskus | 65 | $27,774 | $427 |
| Symbicort | 50 | $16,974 | $339 |
| Spiriva | 27 | $15,247 | $565 |
| Atrovent Hfa | 23 | $8,218 | $357 |
| Incruse Ellipta | 20 | $7,785 | $389 |
| Ventolin Hfa | 99 | $6,054 | $61 |
| Breo Ellipta | 17 | $5,669 | $333 |
| Anoro Ellipta | 11 | $4,438 | $403 |
| Flovent Hfa | 13 | $3,962 | $305 |
| Proair Hfa | 19 | $1,110 | $58 |
| Sildenafil | 12 | $1,059 | $88 |
| Azithromycin | 18 | $442 | $25 |
| Fluticasone Propionate | 33 | $378 | $11 |
| Prednisone | 33 | $240 | $7 |
| Omeprazole | 12 | $84 | $7 |
2017: 16 drugs
| Spiriva | 69 | $31,771 | $460 |
| Advair Diskus | 79 | $30,163 | $382 |
| Symbicort | 53 | $15,738 | $297 |
| Atrovent Hfa | 25 | $8,200 | $328 |
| Incruse Ellipta | 24 | $7,936 | $331 |
| Myrbetriq | 11 | $7,130 | $648 |
| Qvar | 32 | $6,566 | $205 |
| Ventolin Hfa | 69 | $4,660 | $68 |
| Flovent Hfa | 11 | $3,349 | $304 |
| Proair Hfa | 23 | $1,394 | $61 |
| Sildenafil | 22 | $1,349 | $61 |
| Azithromycin | 26 | $427 | $16 |
| Fluticasone Propionate | 26 | $266 | $10 |
| Prednisone | 38 | $237 | $6 |
| Omeprazole | 12 | $109 | $9 |
| Benazepril | 11 | $32 | $3 |
2016: 14 drugs
| Advair Diskus | 97 | $35,921 | $370 |
| Spiriva | 68 | $24,275 | $357 |
| Atrovent Hfa | 41 | $13,928 | $340 |
| Symbicort | 26 | $8,319 | $320 |
| Flovent Hfa | 24 | $8,305 | $346 |
| Dulera | 12 | $3,951 | $329 |
| Ventolin Hfa | 64 | $3,177 | $50 |
| Qvar | 16 | $3,139 | $196 |
| Proair Hfa | 31 | $1,834 | $59 |
| Azithromycin | 27 | $556 | $21 |
| Prednisone | 36 | $274 | $8 |
| Montelukast | 18 | $186 | $10 |
| Omeprazole | 19 | $173 | $9 |
| Fluticasone Propionate | 19 | $139 | $7 |
2015: 14 drugs
| Advair Diskus | 66 | $22,129 | $335 |
| Spiriva | 44 | $21,571 | $490 |
| Sildenafil | 15 | $8,187 | $546 |
| Dulera | 14 | $5,397 | $386 |
| Atrovent Hfa | 18 | $4,219 | $234 |
| Symbicort | 17 | $4,194 | $247 |
| Qvar | 17 | $2,813 | $165 |
| Proair Hfa | 41 | $2,379 | $58 |
| Proventil Hfa | 11 | $679 | $62 |
| Azithromycin | 21 | $297 | $14 |
| Omeprazole | 24 | $269 | $11 |
| Montelukast | 14 | $183 | $13 |
| Prednisone | 21 | $155 | $7 |
| Fluticasone Propionate | 13 | $111 | $9 |
2014: 13 drugs
| Spiriva | 40 | $19,506 | $488 |
| Advair Diskus | 38 | $11,249 | $296 |
| Symbicort | 35 | $9,517 | $272 |
| Atrovent Hfa | 30 | $7,113 | $237 |
| Flovent Hfa | 14 | $4,010 | $286 |
| Qvar | 20 | $3,116 | $156 |
| Proair Hfa | 29 | $1,988 | $69 |
| Proventil Hfa | 15 | $956 | $64 |
| Ventolin Hfa | 14 | $630 | $45 |
| Fluticasone Propionate | 27 | $454 | $17 |
| Prednisone | 25 | $194 | $8 |
| Azithromycin | 13 | $129 | $10 |
| Furosemide | 21 | $109 | $5 |
2013: 9 drugs
| Spiriva | 26 | $11,554 | $444 |
| Advair Diskus | 30 | $8,111 | $270 |
| Proair Hfa | 36 | $3,312 | $92 |
| Flovent Hfa | 11 | $3,071 | $279 |
| Combivent | 11 | $2,661 | $242 |
| Ventolin Hfa | 16 | $808 | $51 |
| Azithromycin | 17 | $520 | $31 |
| Fluticasone Propionate | 15 | $310 | $21 |
| Prednisone | 25 | $133 | $5 |
Money from drug and device companies
$22 in 2025
A payment is not proof that care is biased.
| Actelion Pharmaceuticals US | Uptravi | $22 | 1 payment
|
See the published payment
| Actelion Pharmaceuticals US | Meals · 2025-05-07 | Uptravi | $22 |
Professional record
- NPI
- 1013190370
- Licence
- CA A97424California A97424: Current · expires 2028-09-30
- Trained
- University of California, San Diego School of Medicine, 2005
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 751 S Bascom Ave, Int Med, San Jose, CA, 95128
- NPI first listed
- 2007-12-10
- NPI last updated
- 2007-12-10
This is when the NPI record was last certified, not a medical board exam.